Inspira Technologies to Participate in Upcoming Conferences in September

Rhea-AI Summary

Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) has announced participation in two upcoming virtual conferences. Joe Hayon, Co-Founder and CFO, will be featured at the H.C. Wainwright 23rd Annual Global Investment Conference with an on-demand presentation available from September 13, 2021. He will also present at the Benzinga Small/Mid Cap Healthcare Conference on September 29, 2021, at 10:50 am ET. The company specializes in proprietary respiratory support technologies designed to stabilize patient oxygen levels without invasive mechanical ventilation.

RA'ANANA, Israel, Sept. 9, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company"), a specialty medical device company engaged in the research, development, manufacturing, and marketing of proprietary respiratory support technologies, today announced that Joe Hayon, the Company's Co-Founder and Chief Financial Officer, will participate virtually in the following upcoming conferences:

• H.C. Wainwright 23^rd Annual Global Investment Conference
  Mr. Hayon will have an on-demand presentation available as of Monday, September 13, 2021, at 7:00 am ET. Mr. Hayon will also be available for one-on-one meetings on the same day. To schedule a meeting, contact your H.C. Wainwright representative or Miri Segal at msegal@ms-ir.com. A replay of the presentation will be available on the Company's investor relations page following the event.
• Benzinga Small/Mid Cap Healthcare Conference
  Mr. Hayon will present on Wednesday, September 29 at 10:50 am ET. Mr. Hayon will also be available for one-on-one meetings the same day. To schedule a meeting, contact your Benzinga representative or Miri Segal at msegal@ms-ir.com. Access to the webcast can be found here.

For more information regarding these events, please visit Inspira's Investor Relations page here.  

Inspira Technologies OXY B.H.N. Ltd.

Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology, which it believes will elevate and stabilize patient oxygen saturation levels. The Company's ART technology potentially allows patients to remain awake during treatment while minimizing the use of the highly invasive, risky and costly mechanical ventilation systems that require medically induced coma. The Company's product has not yet been tested or used in humans and has not been approved by the U.S. Food and Drug Administration (FDA).

For more information, please visit our corporate website: https://inspira-technologies.com/

Logo - https://mma.prnewswire.com/media/1534811/Inspira_Technologies_Logo.jpg

For more details:
Miri Segal, Investor Relations, MS-IR LLC 
+917-607-8654, msegal@ms-ir.com

View original content:https://www.prnewswire.com/news-releases/inspira-technologies-to-participate-in-upcoming-conferences-in-september-301372216.html

SOURCE Inspira Technologies

FAQ

What is Inspira Technologies OXY B.H.N. Ltd. known for?

Inspira Technologies OXY B.H.N. Ltd. specializes in innovative respiratory support technologies aimed at stabilizing patient oxygen saturation levels.

When will Joe Hayon present at the H.C. Wainwright conference?

Joe Hayon will have an on-demand presentation available starting September 13, 2021, at 7:00 am ET.

What date will Inspira Technologies present at the Benzinga conference?

Inspira Technologies will present at the Benzinga Small/Mid Cap Healthcare Conference on September 29, 2021, at 10:50 am ET.

How can I access the presentation from the H.C. Wainwright conference?

A replay of the H.C. Wainwright presentation will be available on Inspira's investor relations page following the event.

What technology does Inspira Technologies use for respiratory treatment?

Inspira Technologies has developed Augmented Respiration Technology (ART) to stabilize and elevate patient oxygen saturation levels.